Tumor-specific immune response: Current in vitro analyses may not reflect the in vivo immune status

Critical Reviews in Immunology

Volumn 18, Issue 1-2, 1997, Pages 77-86

  Faure, Florence ^a,b   Even, Jos ^a   Kourilsky, Philippe ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

CDR3; CTL clones; Cytotoxic T lymphocytes; Immunoscope; Melanoma; TCR chains; Tumor infiltrating lymphocytes

Indexed keywords

HLA A2 ANTIGEN; MELANOMA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; LYMPHOCYTE SUBPOPULATION; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE ACTIVATION; TUMOR REJECTION;

EID: 0030690355     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Forsthuber, T., Yip, H. C., and Lehmann, P. V., Induction of Th1 and Th2 immunity in neonatal mice, Science, 271, 1728, 1996.
2. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M., Phenotypic analysis of antigen-specific T lymphocytes, Science, 274, 94-96, 1996.
3. Degiovanni, G., Hainaut, P., Lahaye, T., Weynants, P., and Boon, T., Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells, Eur. J. Immunol., 20, 1865, 23, 1990.
4. Anichini, A., Mortarini, R., Maccalli, C., Squarcina, P., Fleischhauer, K., Mascheroni, L., and Parmiani, G., Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA A2.1-restricted immune repertoire to melanoma, J. Immunol., 156, 208, 1996.
5. Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Panmani, G., Storkus, W. J., and Lotze, M. T., Tumor escape from immune recognition, J. Clin. Invest., 98, 1633, 1996.
6. Dufour, E., Carcelain, G., Gaudin, C., Flament, C., Avril, M. F., and Faure, F., Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines, J. Immunol., 158, 3787-3795, 1997.
7. Sensi, M. L. and Parmiani, G., Analysis of TCR usage in tumors: a new tool for tumor-specific immune response, Immunol. Today, 16, 588, 1995.
8. Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M., and Kourilsky, P., The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments, Proc. Natl. Acad. Sci. U.SA., 90, 2472, 1993.
9. Schwab, R., Szabo, P., Manavalan, J. S., Weksler, M. E., Posnett, D. N., Pannetier, C., Kourilsky, P., and Even, J., Expanded CD4+, CD8+ T cell clones in elderly humans, J. Immunol., 158, 4493-4499, 1997.
10. Pannetier, C., Even, J., and Kourilsky, P., T cell repertoire diversity and clonal expansions in normal and clinical samples, Immunol. Today, 16, 176, 1995.
11. Levraud, J. P., Pannetier, C., Langlade-Demoyen, P., Brichard, V., and Kourilsky, P., Recurrent TCR rearrangements in the CTL response in vivo against the P815 murine tumor, J. Exp. Med., 183, 439-449, 1996.
12. Lehner, P. J., Wang, E. C., Moss, P. A., Williams, S., Platt, K., Friedman, S. M., Bell, J. I., and Borysiewicz, L. K., Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment, J. Exp. Med., 181 (1), 79-91, 1995.
13. Argaet, V. P., Schmidt, C. W., Burrows, S. R., Silins, S. L., Kurilla, M. G., Doolan, D. L., Suhrbier, A., Moss, D. J., Kieff, E., Suclley, T. B., et al., Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus, J. Exp. Med., 180 (6), 2335-2340, 1994.
14. Musette, P., Bequet, D., Delarbre, C., Gachelin, G., Kourilsky, P., and Dormont, D., Expansion of a recurrent Vb5.3 T cell population in newly diagnosed and untreated HLA DR2 multiple sclerosis patients, Proc. Natl. Acad. Sci. U.S.A., 93, 12461-12466, 1996.
15. McHeyzer-Williams, M. G. and Davis, M. M., Antigen-specific development of primary and memory T cells in vivo, Science, 268 (5207), 106-111, 1995.
16. David -Ameline, J., Lim, A., Davodeau, F., Peyrat, M. A., Berthelot, J. M., Semana, G., Gaschet, J., Vie, H., Even, J., and Bonneville, M., Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis, J. Immunol., 157, 4697-4706, 1996.
17. Even, J., Lim, A., Puisieux, I., Ferradini, L., Dietrich, P. Y., Toubert, A., Hercend, T., Triebel, F., Pannetier, C., and Kourilsky, P., T-cell repertoires in healthy and diseased human tissues analyzed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumors and inflammatory diseases, Res. Immunol., 146, 65, 1995.
18. Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M., and Kourilsky, P., Oligoclonality of tumor-infiltrating lymphocytes from human melano-mas, J. Immunol., 153, 2807, 1994.
19. Lim, A., Toubert, A., Pannetier, C., Dougados, M., Charron, D., Kourilsky, P., and Even, J., Spread of clonal T-cell expansions in rheumatoid arthritis, Human Immnnol., 48, 77-83, 1996.
20. Caignard, A., Dietrich, P. Y., Morand, V., Lim, A., Pannetier, C., Leirdant A. M., Hercend, T., Even, J., Kourilsky, P., and Triebel, F., Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck, Cancer Res., 54, 1, 1994.
21. Farace, F., Orlanducci, F., Dietrich, P. Y., Gaudin, C., Angevin, E., Courtier, M, H., Bayle, C., Hercend, T., and Triebel, F., T cell repertoire in patients with B-chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions, J. Immunol., 153, 4281, 1994.
22. Gaudin, C., Dietrich, P. Y., Robache, S., Guillard, M., Escudier, B., Terrier-Lacombe, M. J., Kumar, A., Triebel, F., and Caignard, A., In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma, Cancer Res., 55, 685, 1995.
23. Caignard, A., Guillard, M., Gaudin, C., Escudier, B., Triebel, F., and Dietrich, P-Y., In situ demonstration of renal-cell carcinoma-specific T-cell clones, Int. J. Cancer, 66, 564, 1996.
24. Puisieux, I., Bain, C., Merrouche, Y., Mallancher, P., Kourilsky, P., Even, J., and Favrot, M., Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions, Int. J. Cancer, 66, 201, 1996.
25. Kumar, A., Farace, F., Gaudin, C., and Triebel, F., Clonal T cell expansion induced by interleukin-2 therapy in blood and tumors, J. Clin. Invest., 97, 1219, 1996.
26. Ferradini, L., Mackensen, A., Genevee, C., Bosq, J., Duvillard, P., Avril, M. F., and Hercend, T., Analysis of T cell receptor variability in tumorinfiltrating lymphocytes from a human regressive melanoma, J. Clin. Invest., 91, 1183, 1993.
27. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S., and Hercend, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma, Cancer Res., 53, 3569, 1993.
28. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurkin, C., Szikora, J. P., Renauld, J. C., and Boon, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA A2 melanoma, J. Exp. Med., 180, 35, 1994.
29. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection, Proc. Natl. Acad. Sci. U.S.A., 91, 6458, 1994.
30. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A., Identification of the immunodomin- ant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA A2-restricted tumor-infiltrating lymphocytes, J. Exp. Med., 180, 347, 1994.
31. Spagnoli, C., Schaefer, T. E., Willimann, T., Kocher, A., Amoroso, A., Juretic, M., Zuber, U., Luscher, F., Harder, and Heberer, M., Peptidespecific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan A, gp100 and tyrosinase genes: a study in an unselected group of HLA A2.1 positive patients, Int. J. Cancer, 64, 309, 1995.
32. 27-35, J. Exp. Med., 184, 647-657, 1996.
33. Strand, S., Hofmann, W. J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., and Galle, P. R., Lymphocyte apoptosis induced by CD95 ligand-expressing tumor cells: a mechanism of immune evasion, Nature Med., 2, 1361-1366, 1996.
34. Ford, A. L., Foulcher, E., Lemckert, F. A., and Sedgwick, J. D., Microglia induce CP4 T lymphocyte final effector function and death, J. Exp. Med., 184, 1737-1745, 1996.
35. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier,M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerrotini, J., and Tschopp, J., Melanoma cells expression of Fas ligand: implications for tumor immune escape, Science, 274, 1363-1366, 1996.
36. Walker, P. R., Saas, P., and Dietrich, P. Y., Role of Fas ligand in immune escape, J. Immunol., 158, 4521-4524, 1997.
37. Labarriere, N., Diez,E., Pandolfino, M. C., Viret, C., Guilloux, Y., Leguiner, S., Fonteneau, J. F., Dreno, B., and Jotereau, F., Optimal T cell activation by melanoma cells depends on a minimal level of antigen presentation, J. Immunol., 158, 1238-1245, 1997.
38. Jäger, E., Ringhoffer, M., Altmannsberger, M., Araud, M., Karbach, J., Jäger, D., Oesch, F., and Knuth, A., Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma, Int. J. Cancer, 71, 142-147, 1997.